atorvastatin has been researched along with cremophor el in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZD; Shen, HR; Zhong, MK | 1 |
| Bandivadekar, M; Choudhari, A; Kaul-Ghanekar, R; Koppikar, S; Pancholi, S | 1 |
| Agrawal, AG; Gide, PS; Kumar, A | 1 |
| Aboud, HM; Ali, AA; Hassan, AH; Johnston, TP; Mahmoud, MO | 1 |
4 other study(ies) available for atorvastatin and cremophor el
| Article | Year |
|---|---|
[Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin].
Topics: Administration, Oral; Animals; Area Under Curve; Atorvastatin; Biological Availability; Dogs; Drug Delivery Systems; Emulsions; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Particle Size; Polyethylene Glycols; Pyrroles; Solubility | 2005 |
Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study.
Topics: Anticholesteremic Agents; Atorvastatin; Caco-2 Cells; Chemistry, Pharmaceutical; Drug Delivery Systems; Glycerol; Heptanoic Acids; Humans; Nanoparticles; Particle Size; Permeability; Pyrroles; Solubility; Surface-Active Agents | 2013 |
Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent.
Topics: Abattoirs; Animals; Atorvastatin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Emulsions; Glycerol; Goats; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Nanostructures; Particle Size; Pharmaceutical Vehicles; Phase Transition; Polysorbates; Pyrrolidinones | 2015 |
Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
Topics: Administration, Cutaneous; Animals; Atorvastatin; Biological Availability; Chemistry, Pharmaceutical; Cholesterol; Drug Delivery Systems; Drug Liberation; Esters; Fatty Acids; Glycerides; Glycerol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lecithins; Liver; Male; Nanocapsules; Particle Size; Permeability; Poloxamer; Polyethylene Glycols; Polysorbates; Rats, Wistar; Skin Absorption; Transdermal Patch | 2017 |